Kernel, a leader in non-invasive neuroimaging, announces the publication of their study “Measuring acute effects of subanesthetic ketamine on cerebrovascular...
It’s easy to say that support of psychedelic legalization is spreading when you’re surrounded by psychedelic enthusiasts, but how do you really know?...
PharmaTher Announces Positive Research Results for PharmaPatch™ with N,N-dimethyltryptamine (DMT) and Strategic Investment into Sairiyo Therapeutics The...
The first half of 2023 has come to an end, and so far, this year has been just as action-packed as 2022. The first two quarters...
Cybin Inc. (NEO:CYBN / NYSE American:CYBN), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new...
One of the most powerful psychedelics known, N,N-dimethyltryptamine (DMT) has been described as causing imaginative visuals akin to the dream state. It...
Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine news to help you catch up and stay informed The post News...
A satirical wrap account of Psychedelic Science 2023, a massive psychedelic conference that brought together industries, researchers, and psychonauts,...
There is a sense in the market that a new era has been ushered in for IPO’s. One of the The post CAVA Group’s Bold Move:...
Listen to experienced operators of ketamine clinics from various parts of the country share their journey on starting and administering ketamine-assisted...